Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates


Joint Bone Spine
Sous presse. Epreuves corrigées par l'auteur. Disponible en ligne depuis le mercredi 21 août 2019
Doi : 10.1016/j.jbspin.2019.07.010
accepted : 18 July 2019
Rebound-associated vertebral fractures after stopping denosumab: Report of four cases

Jolan Dupont a, b, , Michaël R. Laurent a, c, d, Lenore Dedeyne a, Frank P. Luyten c, e, Evelien Gielen a, b, c, Marian Dejaeger a, b, c
a Gerontology & Geriatrics, Department of Chronic Diseases, Metabolism and Ageing (CHROMETA), KU Leuven, Herestraat 49 box 7003, 3000 Leuven, Belgium 
b Department of Geriatric Medicine, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium 
c Centre for Metabolic Bone Diseases, University Hospitals Leuven, Herestraat 49, 3000 Leuven, Belgium 
d Imelda Hospital, Imeldalaan 9, 2820 Bonheiden, Belgium 
e Skeletal Biology and Tissue Engineering Centre, Department of Development and Regeneration, KU Leuven, Herestraat 49, 3000 Leuven, Belgium 

Corresponding author at: University Hospitals Leuven, Herestraat 49 PO box 7003, 3000 Leuven, Belgium.University Hospitals LeuvenHerestraat 49 PO box 7003Leuven3000Belgium

Keywords : Bone turnover markers, Denosumab, Osteoporosis, Vertebral fractures, Vertebroplasty, Women

© 2019  Société française de rhumatologie@@#104156@@